Decoy Therapeutics Inc. also files under SLRX, FLKS; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Gauthier Patricia G. | Director | Grant(A) | 2K | — | $0 |
| Aug 31, 2026 | Burleson Tess | Director | Grant(A) | 2K | — | $0 |
| Aug 31, 2026 | Pierce Frederick II | Chief Executive Officer | Grant(A) | 33K | — | $0 |
| Aug 31, 2026 | Hanish Arnold C | Director | Grant(A) | 3K | — | $0 |
| Aug 31, 2026 | McVicar William K. | Director | Grant(A) | 3K | — | $0 |
| Aug 31, 2026 | Lammers Paul | Director | Grant(A) | 2K | — | $0 |
| Aug 31, 2026 | Rosenblum Mark J | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Aug 31, 2026 | Lieber Jonathan I | Director | Grant(A) | 2K | — | $0 |
| Aug 31, 2026 | Marschel Peter Klaus | Chief Business Officer | Grant(A) | 4K | — | $0 |
| Aug 31, 2026 | Hibner Barbara Louise | Chief Scientific Officer | Grant(A) | 4K | — | $0 |
| Dec 30, 2025 | Hanish Arnold C | Director | Sell(S) | 15 | $0.64 | $10 |
| Dec 30, 2025 | Hanish Arnold C | Director | Sell(S) | 12 | $0.64 | $8 |
| Nov 20, 2025 | Hanish Arnold C | Director | Buy(P) | 5K | $0.75 | $4K |
| Nov 20, 2025 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 20K | $0.80 | $16K |
| Apr 11, 2024 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | Hanish Arnold C | Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 23K | — | $0 |
| Feb 20, 2024 | Burleson Tess | Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | McVicar William K. | Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | McCreedy Bruce J Jr. | Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | Lieber Jonathan I | Director | Grant(A) | 21K | — | $0 |
| Feb 20, 2024 | Lammers Paul | Director | Grant(A) | 21K | — | $0 |
| Feb 13, 2023 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 14K | — | $0 |
| Feb 13, 2023 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 6K | — | $0 |
| Jan 3, 2023 | McVicar William K. | Director | Grant(A) | 1K | — | $0 |
| Jan 3, 2023 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 8K | — | $0 |
| Jan 3, 2023 | Lieber Jonathan I | Director | Grant(A) | 1K | — | $0 |
| Jan 3, 2023 | Burleson Tess | Director | Grant(A) | 1K | — | $0 |
| Jan 3, 2023 | McCreedy Bruce J Jr. | Director | Grant(A) | 1K | — | $0 |
| Jan 3, 2023 | Hanish Arnold C | Director | Grant(A) | 1K | — | $0 |
| Jan 3, 2023 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 20K | — | $0 |
| Jan 3, 2023 | Lammers Paul | Director | Grant(A) | 1K | — | $0 |
| Nov 3, 2022 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 3K | $1.73 | $5K |
| Nov 3, 2022 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 1K | $1.73 | $3K |
| Jun 7, 2022 | Burleson Tess | Director | Buy(P) | 28K | $0.18 | $5K |
| Jun 7, 2022 | Lieber Jonathan I | Director | Buy(P) | 38K | $0.19 | $7K |
| Jun 6, 2022 | McVicar William K. | Director | Buy(P) | 27K | $0.19 | $5K |
| Jun 3, 2022 | Hanish Arnold C | Director | Buy(P) | 28K | $0.18 | $5K |
| May 31, 2022 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 28K | $0.18 | $5K |
| May 26, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 19K | $0.18 | $3K |
| May 26, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 3K | $0.18 | $612 |
| May 26, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 11K | $0.18 | $2K |
| May 26, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 10K | $0.18 | $2K |
| May 26, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 708 | $0.18 | $127 |
| May 3, 2022 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 10K | $0.19 | $2K |
| May 3, 2022 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 10K | $0.19 | $2K |
| Mar 3, 2022 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 76K | $0.39 | $30K |
| Mar 3, 2022 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 139K | $0.39 | $54K |
| Jan 20, 2022 | Lieber Jonathan I | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | McCreedy Bruce J Jr. | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | Lammers Paul | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | Hanish Arnold C | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | Burleson Tess | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | McVicar William K. | Director | Grant(A) | 30K | — | $0 |
| Jan 20, 2022 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 200K | — | $0 |
| Jan 20, 2022 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 500K | — | $0 |
| Nov 3, 2021 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 8K | $0.72 | $6K |
| Nov 3, 2021 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 8K | $0.72 | $6K |
| Aug 17, 2021 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 2K | $0.89 | $2K |
| Aug 17, 2021 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 2K | $0.90 | $2K |
| Aug 10, 2021 | Hanish Arnold C | Director | Buy(P) | 7K | $0.88 | $6K |
| May 3, 2021 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 10K | $0.57 | $5K |
| May 3, 2021 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 10K | $0.57 | $6K |
| Dec 2, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 80K | — | $0 |
| Dec 2, 2020 | Hanish Arnold C | Director | Grant(A) | 30K | — | $0 |
| Dec 2, 2020 | Lieber Jonathan I | Director | Grant(A) | 30K | — | $0 |
| Dec 2, 2020 | McCreedy Bruce J Jr. | Director | Grant(A) | 30K | — | $0 |
| Dec 2, 2020 | Lammers Paul | Director | Grant(A) | 30K | — | $0 |
| Dec 2, 2020 | Burleson Tess | Director | Grant(A) | 30K | — | $0 |
| Dec 2, 2020 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 275K | — | $0 |
| Dec 2, 2020 | McVicar William K. | Director | Grant(A) | 30K | — | $0 |
| Nov 3, 2020 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 5K | $0.56 | $3K |
| Nov 3, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 5K | $0.56 | $3K |
| Aug 21, 2020 | Hanish Arnold C | Director | Buy(P) | 4K | $0.98 | $4K |
| Aug 19, 2020 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 1K | $1.01 | $1K |
| Aug 19, 2020 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 1K | $1.01 | $1K |
| Aug 17, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 5K | $1.00 | $5K |
| Jul 14, 2020 | Lieber Jonathan I | Director | Grant(A) | 3K | — | $0 |
| Jul 14, 2020 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 340K | — | $0 |
| Jul 14, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 50K | — | $0 |
| Mar 23, 2020 | Northrup Jonathan P | Director | Grant(A) | 6K | — | $0 |
| Mar 23, 2020 | McCreedy Bruce J Jr. | Director | Grant(A) | 6K | — | $0 |
| Mar 23, 2020 | Burleson Tess | Director | Grant(A) | 6K | — | $0 |
| Mar 23, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Grant(A) | 30K | — | $0 |
| Mar 23, 2020 | Hanish Arnold C | Director | Grant(A) | 6K | — | $0 |
| Mar 23, 2020 | Arthur David J. | Chief Executive Officer, Director | Grant(A) | 60K | — | $0 |
| Mar 23, 2020 | Lammers Paul | Director | Grant(A) | 6K | — | $0 |
| Mar 23, 2020 | McVicar William K. | Director | Grant(A) | 6K | — | $0 |
| Feb 19, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 2K | $0.95 | $2K |
| Feb 18, 2020 | Jordan Scott | Chief Business Officer | Buy(P) | 11K | $0.90 | $10K |
| Feb 13, 2020 | Rosenblum Mark J | Exec VP Finance, CFO | Buy(P) | 5K | $0.86 | $4K |
| Feb 11, 2020 | Arthur David J. | Chief Executive Officer, Director | Buy(P) | 2K | $0.01 | $22 |
| Feb 11, 2020 | Northrup Jonathan P | Director | Buy(P) | 9K | $0.01 | $87 |
| Feb 11, 2020 | Burleson Tess | Director | Buy(P) | 4K | $0.01 | $44 |
| Feb 11, 2020 | McVicar William K. | Director | Buy(P) | 9K | $0.01 | $87 |
| Feb 11, 2020 | Hanish Arnold C | Director | Buy(P) | 4K | $0.01 | $44 |
| Feb 11, 2020 | McCreedy Bruce J Jr. | Director | Buy(P) | 9K | $0.01 | $87 |
| Feb 11, 2020 | McVicar William K. | Director | Buy(P) | 9K | $1.15 | $10K |
| Feb 11, 2020 | Northrup Jonathan P | Director | Buy(P) | 9K | $1.15 | $10K |
| Feb 11, 2020 | Burleson Tess | Director | Buy(P) | 4K | $1.15 | $5K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Decoy Therapeutics Inc., SEC CIK 0001615219. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under DCOY and shows every filing by that issuer (also filed as SLRX, FLKS).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for DCOY